Argentina - Re-Import of Heparin for Therapeutic Use
Since 2014, Argentina Re-Import of Heparin for Therapeutic Use fell by 13.7% year on year. In 2019, the country was ranked number 5 comparing other countries in Re-Import of Heparin for Therapeutic Use at $282,142.75. Argentina is overtaken by France, which was ranked number 4 with $378,030.03 and is followed by New Zealand with $40,139.76. Canada lead the ranking with $1,738,281.5 in 2019, that is a growth of 72.9% versus 2018. Australia recorded the best 5 years average growth at +309.1% per year, while Thailand recorded the worst performance at -47.1% per year.
| Date | US Dollars |
|---|---|
| 2019 | 282,142.75 |
| 2018 | 133,947.89 |
| 2017 | 545,814.75 |
| 2016 | 682,022.31 |
| 2015 | 269.00 |
Download all data from 2009 to 2019
How does Argentina rank in Re-Import of Heparin for Therapeutic Use?
| # | 9 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Canada
|
1,738,281.50 | 2019 | +72.9 % | +112.5 % | View data | |
| 2 |
#2
Australia
|
1,253,862.50 | 2019 | +10.8 % | +309.1 % | View data | |
| 4 |
#4
France
|
378,030.03 | 2019 | -14.2 % | -8.6 % | View data | |
| 5 |
#5
Argentina
|
282,142.75 | 2019 | +110.6 % | -13.7 % | View data | |
| 6 |
#6
New Zealand
|
40,139.76 | 2019 | +27.3 % | +60.2 % | View data | |